These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 8475570)
1. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Li X; Faustman D Transplantation; 1993 Apr; 55(4):940-6. PubMed ID: 8475570 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
3. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293 [TBL] [Abstract][Full Text] [Related]
4. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991 [TBL] [Abstract][Full Text] [Related]
5. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337 [TBL] [Abstract][Full Text] [Related]
7. NK cell tolerance in mixed allogeneic chimeras. Zhao Y; Ohdan H; Manilay JO; Sykes M J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414 [TBL] [Abstract][Full Text] [Related]
8. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954 [TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of class I deficient mouse islet allografts but not xenografts. Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641 [No Abstract] [Full Text] [Related]
10. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice. Tanaka K; Yamada J; Streilein JW Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1827-32. PubMed ID: 10845605 [TBL] [Abstract][Full Text] [Related]
11. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model. Pollak R; Blanchard JM Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654 [TBL] [Abstract][Full Text] [Related]
12. Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice. Shenoy S; Desch K; Duffy B; Thorson P; Mohanakumar T Clin Exp Immunol; 1998 May; 112(2):188-95. PubMed ID: 9649180 [TBL] [Abstract][Full Text] [Related]
13. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Osorio RW; Ascher NL; Stock PG Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021 [TBL] [Abstract][Full Text] [Related]
14. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice. Gordon EJ; Kelkar V Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653 [TBL] [Abstract][Full Text] [Related]
15. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075 [TBL] [Abstract][Full Text] [Related]
16. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes. Osawa H; Streilein JW Cornea; 2005 Apr; 24(3):312-8. PubMed ID: 15778605 [TBL] [Abstract][Full Text] [Related]
17. Skin graft rejection by beta 2-microglobulin-deficient mice. Zijlstra M; Auchincloss H; Loring JM; Chase CM; Russell PS; Jaenisch R J Exp Med; 1992 Apr; 175(4):885-93. PubMed ID: 1552287 [TBL] [Abstract][Full Text] [Related]
18. A major role for host MHC class I antigen presentation for promoting islet allograft survival. Beilke J; Johnson Z; Kuhl N; Gill RG Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts. Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816 [TBL] [Abstract][Full Text] [Related]
20. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells. Tanaka K; Sonoda K; Streilein JW Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]